Retour

Explorez tous les épisodes du podcast JACC Specialty Journals

Plongez dans la liste complète des épisodes de JACC Specialty Journals. Chaque épisode est catalogué accompagné de descriptions détaillées, ce qui facilite la recherche et l'exploration de sujets spécifiques. Suivez tous les épisodes de votre podcast préféré et ne manquez aucun contenu pertinent.

Rows per page:

1–50 of 2,021

TitreDateDurée
Infective Endocarditis of Transcatheter Aortic Valve Replacement and Transcatheter Edge to Edge Repair Devices | JACC: Advances14 Aug 202600:18:44

Nicole Bhave, Michael Reardon, and Joe Aoun discuss what inspired their paper, the unique microbiology of TAVR endocarditis, and a challenging endocarditis case example.

Tailoring Antiplatelet Therapy Duration After PFO Closure: Insights from the PROLONG Registry | JACC: Advances12 Aug 202600:25:58

Akl Fahed and Carlo Gaspardone discuss the impact of APT duration on long-term outcomes after PFO closure.

The Postnatal Lung Maturation Disrupted by Increased Pulmonary Blood Flow and Its Clinical Implications | JACC: Asia06 Aug 202600:03:30

Commentary by Dr. Xinqi Zhong.

His-Pacing versus Biventricular Pacing for Cardiac Resynchronization Therapy: Long-term follow-up from the His-alternative I Trial | JACC: Clinical Electrophysiology14 Apr 202600:02:56

In this episode of JACC: Clinical Electrophysiology, Deputy Editor Dr. Kenneth Ellenbogen discusses His-Pacing versus Biventricular Pacing for Cardiac Resynchronization Therapy: Long-term follow-up from the His-alternative I Trial.

JACC: Cardiovascular Interventions - A Prospective, Multicenter, Real-World Registry of Coronary Lithotripsy in Calcified Coronary Arteries: The REPLICA-EPIC18 Study29 Mar 202400:10:12

Commentary by Dr. Mirza Umair Khalid and Dr. Oriol Rodriguez-Leor

JACC: Advances - Prevalence and Prognostic Implications of Pulmonary Hypertension in Patients With Severe Aortic Regurgitation27 Mar 202400:03:28

Commentary by Dr. Candice Silversides

JACC: Advances - Effect of Sex and Flow Status on Outcomes After Surgical or Transcatheter Aortic Valve Replacement27 Mar 202400:02:46

Commentary by Dr. Candice Silversides

JACC: Advances - Quantifying the Survival Loss Linked to Late Therapeutic Indication in High-Gradient Severe Aortic Stenosis27 Mar 202400:03:29

Commentary by Dr. Candice Silversides

JACC: Advances - Left Ventricular Noncompaction in Childhood: Echocardiographic Follow-Up and Prevalence in First-Degree Relatives27 Mar 202400:02:44

Commentary by Dr. Candice Silversides

JACC: Advances - Long-Term Arrhythmic Follow-Up and Risk Stratification of Patients With Desmoplakin-Associated Arrhythmogenic Right Ventricular Cardiomyopathy27 Mar 202400:03:15

Commentary by Dr. Candice Silversides

JACC: Advances - Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-1927 Mar 202400:02:41

Commentary by Dr. Candice Silversides

JACC: Advances - Training Paradigms in Critical Care Cardiology: A Scoping Review of Current Literature27 Mar 202400:03:05

Commentary by Dr. Candice Silversides

JACC: Advances - First Experience With Augmented Reality Guidance for Cerebral Embolic Protection During TAVR27 Mar 202400:02:49

Commentary by Dr. Candice Silversides

JACC: Advances - Myocardial Blood Flow Quantified Using Stress Cardiac Magnetic Resonance After Mild COVID-19 Infection27 Mar 202400:02:33

Commentary by Dr. Candice Silversides

Return-to-Play for Athletes with Desmosomal Arrhythmogenic Cardiomyopathy: A Single Center Experience | JACC: Clinical Electrophysiology14 Apr 202600:05:46

Deputy Editor Kenneth Ellenbogen hosts a focused discussion on the study "Return‑to‑Play for Athletes with Desmosomal Arrhythmogenic Cardiomyopathy: A Single Center Experience." In this episode, Dr. Ellenbogen examines how desmosomal arrhythmogenic cardiomyopathy impacts athletic participation and highlights real‑world insights from a single‑center cohort. He walks listeners through the clinical considerations, risk assessment strategies, and decision‑making frameworks that guide safe return‑to‑play recommendations for competitive athletes. This conversation offers valuable perspective for clinicians navigating the balance between athletic performance and long‑term cardiovascular safety.

JACC: Advances - Technical Success and Serious Adverse Events for Fetal Aortic Valvuloplasty in a Large 20-Year Cohort27 Mar 202400:03:10

Commentary by Dr. Candice Silversides

JACC: Advances - Preoperative Hemodynamics Impact the Benefit of Fenestration on Fontan Postoperative Length of Stay27 Mar 202400:02:50

Commentary by Dr. Candice Silversides

JACC: Advances - The Causal-Benefit Model to Prevent Cardiovascular Events27 Mar 202400:17:52

Commentary by Dr. Sadeer Al-Kindi and Dr. Allan Sniderman

JACC: Advances - Proposal and Rationale for a Cardioethics Curriculum27 Mar 202400:13:13

Commentary by Dr. Candice Silversides and Dr. James Kirkpatrick

JACC: Advances - Hypertensive Disorders of Pregnancy: Innovative Management Strategies27 Mar 202400:15:09

Commentary by Dr. Candice Silversides and Dr. Anna Bortnick

JACC: CardioOncology Pulse - Induced Pluripotent Stem Cells in Cardio-Oncology26 Mar 202400:23:18

Joseph Wu, MD, PhD discusses how stem cells are being employed to better understand mechanisms of cancer therapy-related cardiotoxicity. Moderated by Nicholas Wilcox, MD, MHS.

JACC: CardioOncology Pulse - Top Takeaways on 'Spotlight on Lung Cancer: Insights into Radiation, Immune Checkpoint Inhibitor, and Epidermal Growth Factor Receptor Therapies' at ACC Advancing the Cardiovascular Care of the Cancer Patient26 Mar 202400:13:15

Teresa López-Fernández, MD, and Lova Sun, MD, MSCE discuss the key cardiotoxicities for lung cancer therapy, including radiation, epidermal growth factor receptor and immune checkpoint inhibitor therapy.

JACC: CardioOncology Pulse - Top Takeaways on 'Surviving and Thriving: Promoting Cardiovascular Health in Adult Survivors of Childhood Cancers' at ACC Advancing the Cardiovascular Care of the Cancer Patient26 Mar 202400:06:59

Richard Cheng, MD, and Stephanie Dixon, MD, provide a review on practical takeaways for cardio-oncologists who are caring for adult survivors of childhood cancer.

JACC: CardioOncology Pulse - Top Takeaways on 'Perspective from the FDA: How to Keep Pace with New Drug Development and Drug Safety' at ACC Advancing the Cardiovascular Care of the Cancer Patient26 Mar 202400:09:54

Ana Barac, MD, PhD, and Laleh Amiri-Kordestani, MD, offer a unique perspective on the development and safety of novel therapeutics, with a focus on cardio-oncology.

JACC Edge Podcast - CV Care Team: There's No I in Team21 Mar 202400:23:03

Commentary by Drs. Pratik Doshi and ACC Immediate Past President Edward Fry discussing how the field of cardiology is becoming increasingly dynamic and requires us to expand the cardiac service line beyond the physician.

Functional Conduction Block During Extra-Stimulus Mapping Masks Deceleration Zones and Reveals Additional VT Substrate | JACC: Clinical Electrophysiology14 Apr 202600:04:59

Deputy Editor Francis Marchlinski hosts a deep‑dive discussion on the study "Functional Conduction Block During Extra‑Stimulus Mapping Masks Deceleration Zones and Reveals Additional VT Substrate." In this episode, Dr. Marchlinski explores how extra‑stimulus pacing can alter the visualization of critical conduction deceleration zones and uncover previously hidden components of the ventricular tachycardia substrate. He breaks down the clinical implications of these dynamic changes and what they mean for improving VT mapping and ablation strategies.

JACC: Advances Pulse - Critical Care Cardiology: When and How19 Mar 202400:33:00

In this inaugural episode of JACC:Advances Pulse, Dr Jason Katz & Dr Shashank Sinha share their invaluable insights on the present and future of Critical Care Cardiology with moderators by Dr Anju Bhardwaj & Dr Sadeer Al-Kindi. Hear more about the various training pathways in Critical Care Cardiology and the future of the field.

JACC: Advances Pulse - Cardiometabolic Health Clinic19 Mar 202400:20:07

In this episode of JACC: Advances Pulse, Dr. Erin Michos and Dr. Ambarish Pandey discuss the role of multidisciplinary cardio-metabolic health clinics in the current landscape of cardiovascular diseases with moderator Dr. Anju Bhardwaj. Hear more about how these comprehensive specialty clinics are helping cardiovascular outcomes risk factor by risk factor.

JACC Edge Podcast - Global Health: We Are the World07 Mar 202400:24:48

Commentary by Dr. Pratik Doshi and ACC President Dr. Hadley Wilson discussing how the cardiology community can drive improvements in global health through research and global action.

JACC: Advances - Virtual Reality for Pain and Anxiety Management in Cardiac Surgery and Interventional Cardiology06 Mar 202400:18:23

Commentary by Drs. Candice Silversides, Sulayman el Mathari, and Jolanda Kluin

JACC: Asia - Prasugrel Monotherapy After Percutaneous Coronary Intervention for Chronic Coronary Syndrome: Insights From ASET Pilot Studies05 Mar 202400:05:10

Commentary by Dr Duk-Woo Park

JACC: Asia - Prognostic Implication of Platelet Reactivity According to Procedural Complexity After PCI: Subanalysis of PTRG-DES Consortium05 Mar 202400:04:10

Commentary by Dr Osung Kwon

JACC: Asia - Sex Differences in Clinical Outcomes Associated With Quantitative Flow Ratio-Guided Percutaneous Coronary Intervention05 Mar 202400:03:42

Commentary by Dr Christopher Wong

JACC: Asia - Differential Impact of Fractional Flow Reserve Measured After Coronary Stent Implantation by Left Ventricular Dysfunction05 Mar 202400:03:40

Commentary by Dr William F. Fearon

JACC: Asia - March 1, 2024 Issue Summary05 Mar 202400:18:10

Audio Summary of the March 1, 2024 Issue by Dr. Jian'an Wang

JACC: Clinical Electrophysiology - Impact of Atrial Fibrillation Burden on Healthcare Costs and Utilization28 Feb 202400:06:34

Commentary by Dr. Ratika Parkash

LONG-TERM OUTCOMES AND SAFETY OF HIS-PURKINJE CONDUCTION SYSTEM PACING: A MULTICENTER OBSERVATIONAL STUDY IN CHINA (The ChiCSP Study)14 Apr 202600:04:14

Dr. Kenneth Ellebogen, Deputy Editor of JACC: Clinical Electrophysiology, discusses the long-term outcomes and safety of His-Purkinje conduction system pacing: a multicenter observational study in China.

JACC: Advances - Underrepresentation of Diverse Ancestries Drives Uncertainty in Genetic Variants Found in Cardiomyopathy-Associated Genes28 Feb 202400:03:04

Commentary by Dr. Candice Silversides

JACC: Advances - Cardiovascular and Non-Cardiovascular Prescribing and Mortality After Takotsubo: Comparison With Myocardial Infarction and General Population28 Feb 202400:02:36

Commentary by Dr. Candice Silversides

JACC: Advances - Renal Biomarkers in Heart Failure: Systematic Review and Meta-Analysis28 Feb 202400:02:44

Commentary by Dr. Candice Silversides

JACC: Advances - Sex-Based Differences in Patients With Left Ventricular-Assisted Devices and Strokes28 Feb 202400:02:43

Commentary by Dr. Candice Silversides

JACC: Advances - Nontraditional Risk Markers for Incident Coronary Artery Calcium Among Persons ≥65 Years of Age28 Feb 202400:03:12

Commentary by Dr. Candice Silversides

JACC: Advances - Air Pollution and Adverse Cardiovascular Events After Coronary Artery Bypass Grafting: A 10-Year Nationwide Study28 Feb 202400:03:24

Commentary by Dr. Candice Silversides

JACC: Advances - Sex Differences in Coronary Artery Disease Characteristics Among Patients With Type 2 Myocardial Infarction28 Feb 202400:07:55

Commentary by Dr. Anju Bhardwaj and Dr. Jim Januzzi

JACC: Advances - Psychological Distress and the Risk of Adverse Cardiovascular Outcomes in Patients With Coronary Heart Disease28 Feb 202400:02:27

Commentary by Dr. Candice Silversides

JACC: Advances - Vitamin D Deficiency, Inflammation, and Diminished Endogenous Regenerative Capacity in Coronary Heart Disease28 Feb 202400:03:33

Commentary by Dr. Candice Silversides

JACC: Advances - Multimarker Approach to Improve Risk Stratification of Patients Undergoing Transcatheter Aortic Valve Implantation28 Feb 202400:14:14

Commentary by Dr. Bailey Estes and Dr. Philippe Pibarot

His Pacing vs Biventricular Pacing for Cardiac Resynchronization Therapy | JACC: Clinical Electrophysiology13 Apr 202600:02:56

In this episode, Dr. Kenneth Ellenbogen, Deputy Editor of JACC: Clinical Electrophysiology, discusses new long-term findings from the His-Alternative I trial, the first European randomized study comparing His-bundle pacing with conventional biventricular pacing for cardiac resynchronization therapy (CRT). He highlights five-year outcomes demonstrating that when His-bundle pacing is achieved with low implant thresholds, its long-term performance—including lead stability, generator replacements, and clinical response—closely mirrors that of biventricular CRT. Dr. Ellenbogen explores the implications of these results for contemporary conduction system pacing practice, the importance of strict implant criteria, and how these data help refine patient selection and procedural strategy in CRT.

JACC: Advances - Rivaroxaban vs Vitamin K Antagonist in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease28 Feb 202400:03:00

Commentary by Dr. Candice Silversides

JACC: Advances - Associations Between Cardiac Function and Brain Health in Diverse Middle-Aged Adults: The Dallas Heart Study-228 Feb 202400:02:46

Commentary by Dr. Candice Silversides

© My Podcast Data · Projet indépendant · Données issues d'Apple & Spotify